I agree that this site is using cookies. You can find further informations here.
X
Urigüen, L.
396  results:
Search for persons X
?
1

Metabolomic analysis of plasma samples from schizophrenia p..:

Callado, L.F. ; Villate, A. ; Olivares, M....
Neuroscience Applied.  2 (2023)  - p. 103720 , 2023
Link: https://doi.org/10.1016/..
 
?
2

Behavioural evaluation and assessment of the Akt/mTOR pathw..:

Unzueta-Larrinaga, P. ; Barrena-Barbadillo, R. ; Iñiguez, S....
Neuroscience Applied.  2 (2023)  - p. 103577 , 2023
Link: https://doi.org/10.1016/..
 
?
3

Obtaining neurons and glia from the olfactory neuroepitheli..:

Unzueta-Larrinaga, P. ; Barrena-Barbadillo, R. ; Callado, L.F..
Neuroscience Applied.  2 (2023)  - p. 101026 , 2023
Link: https://doi.org/10.1016/..
 
?
4

Transcriptomic fingerprint of neurons and glial cells isola..:

Urigüen, L. ; Unzueta-Larrinaga, P. ; Barrena-Barbadillo, R....
Neuroscience Applied.  2 (2023)  - p. 103672 , 2023
Link: https://doi.org/10.1016/..
 
?
5

P.0907 Cannabis abuse differently regulates 5-HT2A receptor..:

Unzueta-Larrinaga, P. ; Ibarra-Lecue, I. ; Barrena-Barbadillo, R....
European Neuropsychopharmacology.  53 (2021)  - p. S666-S667 , 2021
Link: https://doi.org/10.1016/..
 
?
6

Decreased ribosomal protein S6 phosphorylation in post-mort..:

Callado, L.F. ; Ibarra-Lecue, I. ; Diez-Alarcia, R...
European Neuropsychopharmacology.  29 (2019)  - p. S321 , 2019
Link: https://doi.org/10.1016/..
 
?
7

IPR-166: a potent and selective prolyl oligopeptidase inhib..:

Prades, R. ; Munarriz-Cuezva, E. ; Urigüen, L...
European Neuropsychopharmacology.  29 (2019)  - p. S244 , 2019
Link: https://doi.org/10.1016/..
 
?
8

Chronic tetrahydrocannabinol and psychotic-like symptoms in..:

Ibarra, I. ; Mollinedo-Gajate, I. ; Meana, J.J....
European Neuropsychopharmacology.  28 (2018)  - p. S50-S51 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Effect of chronic THC administration in the reproductive or..:

López-Cardona, A.P. ; Ibarra-Lecue, I. ; Laguna-Barraza, R....
Biochemical Pharmacology.  157 (2018)  - p. 294-303 , 2018
Link: https://doi.org/10.1016/..
 
?
10

Docosahexaenoic Acid Reduces Cerebral Damage and Ameliorate..:

Arteaga, Olatz ; Revuelta, M. ; Urigüen, L....
Molecular Neurobiology.  54 (2016)  9 - p. 7137-7155 , 2016
Link: https://doi.org/10.1007/..
 
?
11

P.3.c.002 Selective prolyl oligopeptidase inhibition by IPR..:

Prades, R. ; Munarriza-Cuezva, E. ; Urigüen, L....
European Neuropsychopharmacology.  25 (2015)  - p. S479-S480 , 2015
Link: https://doi.org/10.1016/..
 
?
12

P.3.c.001 The prolyl oligopeptidase inhibitor IPR19 improve..:

Munarriz-Cuezva, E. ; Prades, R. ; Urigüen, L....
European Neuropsychopharmacology.  25 (2015)  - p. S479 , 2015
Link: https://doi.org/10.1016/..
 
?
13

Behavioral, neurochemical and morphological changes induced..:

Urigüen, L ; Gil-Pisa, I ; Munarriz-Cuezva, E...
Translational Psychiatry.  3 (2013)  1 - p. e221-e221 , 2013
Link: https://doi.org/10.1038/..
 
?
14

P.3.f.005 A2A-adenosine, D2-dopamine and CB1-cannabinoid re..:

Urigüen, L. ; García-Fuster, M.J. ; Callado, L.F....
European Neuropsychopharmacology.  18 (2008)  - p. S476-S477 , 2008
Link: https://doi.org/10.1016/..
 
?
15

P.6.b.001 Study of the cannabinoid CB1 receptor funcionalit..:

Callado, L.F. ; Erdozain, A.M. ; Urigüen, L..
European Neuropsychopharmacology.  18 (2008)  - p. S527 , 2008
Link: https://doi.org/10.1016/..
 
1-15